Sinoma Science & Technologyに関するコメント

The company's consistent ROCE and capital increase suggest it's not investing in high return ventures. Market expects improvement, but the outlook may be negative if trends don't change.

Projecting a lower earnings growth, investors expect limited future growth and are paying less for Sinoma Science & Technology's stock, resulting in a lower P/E ratio. Absent unexpected earnings surprises, future share price growth may be limited.

Despite lowering EPS estimates, Sinoma Science & Technology's stocks won't see a decline, say analysts. It's projected to witness 35% revenue growth in 2024, outstripping its industry.

Investors may view this as a chance to buy, given the company's promising profit outlook and potential future gains amidst high price volatility. Despite this, factors like capital structure and management's track record should be acknowledged before investing, as the positive outlook is not yet fully mirrored in the share price.